Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.66 USD | -6.80% | -15.12% | +7.62% |
Feb. 29 | Puma Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 29 | Transcript : Puma Biotechnology, Inc., Q4 2023 Earnings Call, Feb 29, 2024 |
Financials (USD)
Sales 2024 * | 231M | Sales 2025 * | 233M | Capitalization | 225M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 14M | EV / Sales 2024 * | 0.97 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
18
x | P/E ratio 2025 * |
27.6
x | Employees | 185 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.17% |
Latest transcript on Puma Biotechnology, Inc.
1 day | -6.80% | ||
1 week | -15.12% | ||
Current month | -25.08% | ||
1 month | -34.46% | ||
3 months | +17.97% | ||
6 months | +54.82% | ||
Current year | +7.62% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 4.66 | -6.80% | 1,324,785 |
24-03-15 | 5 | -4.21% | 422,501 |
24-03-14 | 5.22 | -2.06% | 464,927 |
24-03-13 | 5.33 | -0.37% | 249,018 |
24-03-12 | 5.35 | -2.55% | 453,150 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.62% | 225M | |
+9.72% | 46.21B | |
+34.78% | 40.04B | |
+4.84% | 39.92B | |
-9.43% | 28.33B | |
+17.47% | 27.43B | |
-22.99% | 18.57B | |
+10.88% | 13.46B | |
+27.53% | 12.02B | |
-6.84% | 11.3B |